Preventing Diabetes in Primary Care: Providers’ Perspectives About Diagnosing and Treating Prediabetes
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
IN BRIEF Offering patient-centered care to prevent diabetes will require collaborative decision-making between patients with prediabetes and their health care providers. From the perspective of primary care providers, prediabetes detection should be targeted to patients who are most likely to benefit from diagnosis and treatment. Improving access to lifestyle intervention programs and educating providers about evidence-based treatments for prediabetes and how to effectively discuss treatment options with patients may improve both providers’ and patients’ engagement in diabetes prevention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
(2002) · New England Journal of Medicine · doi:10.1056/nejmoa012512 · Cited by 19,011 · cited 1×
“These materials were developed using 3-year data from the DPP clinical trial (30) and included visual representations of numerical data based on current best practices.”
MethodTuomilehto, J., Lindström, J., Eriksson, J. G., Valle, T. T., Hämäläinen, H., Ilanne-Parikka, P., Keinänen-Kiukaanniemi, S., Laakso, M., Louheranta, A., Rastas, M., et al. (2001) · New England Journal of Medicine · doi:10.1056/nejm200105033441801 · Cited by 10,873
Shared decision making: A model for clinical practice
Elwyn, G., Frosch, D., Thomson, R., Joseph-Williams, N., Lloyd, A., Kinnersley, P., Cording, E., Tomson, D., Dodd, C., Rollnick, S., et al. (2012) · Journal of General Internal Medicine · doi:10.1007/s11606-012-2077-6 · Cited by 4,405 · cited 1×
“Shared decision-making has been defined as “an approach where clinicians and patients share the best available evidence when faced with the task of making decisions, and where patients are supported to consider options and to achieve informed preferences” (25).”
BackgroundSample size in qualitative research
Sandelowski, M. (1995) · Research in Nursing & Health · doi:10.1002/nur.4770180211 · Cited by 4,372
Ramachandran, A., Snehalatha, C., Mary, S., Mukesh, B., Bhaskar, A. D., Vijay, V., & Indian Diabetes Prevention Programme (IDPP) (2006) · Diabetologia · doi:10.1007/s00125-005-0097-z · Cited by 1,881
Impaired Fasting Glucose and Impaired Glucose Tolerance
Nathan, D. M., Davidson, M. B., DeFronzo, R. A., Heine, R. J., Henry, R. R., Pratley, R., & Zinman, B. (2007) · Diabetes Care · doi:10.2337/dc07-9920 · Cited by 1,396 · cited 1×
“An estimated 86 million American adults have prediabetes (1), 70% of whom will ultimately develop type 2 diabetes (2).”
Background(2015) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(15)00291-0 · Cited by 1,029
Shared decision making: really putting patients at the centre of healthcare
Stiggelbout, A. M., Weijden, T. V. D., Wit, M. P. T. D., Frosch, D., Legare, F., Montori, V. M., Trevena, L., & Elwyn, G. (2012) · BMJ · doi:10.1136/bmj.e256 · Cited by 1,014 · cited 1×
“We conducted in-depth interviews using a semi-structured interview guide that was informed by shared decision-making theory, which represents an effective framework for using evidence in routine clinical practice, including extensive application in diabetes (23,24).”
MethodLi, G., Zhang, P., Wang, J., An, Y., Gong, Q., Gregg, E. W., Yang, W., Zhang, B., Shuai, Y., Hong, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70057-9 · Cited by 684 · cited 1×
“However, there is mounting evidence that ILI reduces both mortality and the risk of microand macrovascular complications in patients with prediabetes (9,10).”
BackgroundSiu, A. L., & on behalf of the U.S. Preventive Services Task Force* (2015) · Annals of Internal Medicine · doi:10.7326/m15-2345 · Cited by 319
Gong, Q., Gregg, E. W., Wang, J., An, Y., Zhang, P., Yang, W., Li, H., Li, H., Jiang, Y., Shuai, Y., et al. (2011) · Diabetologia · doi:10.1007/s00125-010-1948-9 · Cited by 251
Moin, T., Li, J., Duru, O. K., Ettner, S., Turk, N., Keckhafer, A., Ho, S., & Mangione, C. M. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1773 · Cited by 90
Metformin Use in Prediabetes Among U.S. Adults, 2005–2012
Tseng, E., Yeh, H.-C., & Maruthur, N. M. (2017) · Diabetes Care · doi:10.2337/dc16-1509 · Cited by 72
Schmittdiel, J. A., Adams, S. R., Segal, J., Griffin, M. R., Roumie, C. L., Ohnsorg, K., Grant, R. W., & O’Connor, P. J. (2014) · Diabetes Care · doi:10.2337/dc13-1223 · Cited by 68 · cited 1×
“Despite strong evidence supporting ILI and metformin, neither treatment is routinely used to prevent diabetes (12,13).”
Background
Cited by
Evidence and challenges for translation and population impact of the Diabetes Prevention Program.
Ackermann, R. T., & O’Brien, M. J. (2020) · Current Diabetes Reports · doi:10.1007/s11892-020-1293-4 · Cited by 62
Self-citationChakkalakal, R. J., Galaviz, K. I., Thirunavukkarasu, S., Shah, M. K., & Narayan, K. M. V. (2024) · Annual Review of Public Health · doi:10.1146/annurev-publhealth-060222-023417 · Cited by 35
Significance of prediabetes as a nosological entity
Stepanek, L., Horakova, D., Nakladalova, M., Cibickova, L., Karasek, D., & Zadrazil, J. (2018) · Biomedical Papers · doi:10.5507/bp.2018.057 · Cited by 7
Metadata
- Authors
- Kandula, N. R., Moran, M. R., Tang, J. W., & O’Brien, M. J.
- Venue
- Clinical Diabetes
- Publisher
- American Diabetes Association
- Published
- 2018-01-01
- Volume
- 36
- Issue
- 1
- Pages
- 59-66
- ISSN
- 0891-8929 (ISSN-L)
- 1945-4953
- OpenAlex
- W2770453482
- Cited by
- 42
- References
- 14
- FWCI
- 1.30
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.